Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide

Tuberous sclerosis complex (TSC) is a genetic disorder characterised by highly variable comorbid dysfunction and subsequent morbidity. The mTOR inhibitor everolimus is indicated for the treatment of adult TSC patients with renal angiomyolipomas (AMLs) and for subependymal giant astrocytoma (SEGA) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Mark, Saxena, Anurag, Kingswood, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311836/
https://www.ncbi.nlm.nih.gov/pubmed/28202028
http://dx.doi.org/10.1186/s13023-017-0581-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311836/
https://www.ncbi.nlm.nih.gov/pubmed/28202028
http://dx.doi.org/10.1186/s13023-017-0581-9

Ejemplares similares